Eshita Khera

Company: Novartis BioMedical Research

Job title: Principal Scientist I

Bio:

Seminars:

Exploring the Design of Selectively-Targeted Payloads with Quantitative Systems Pharmacology 4:00 pm

There is emerging interest in developing ADCs with selectively-targeted payloads such as protein inhibitors and degraders Empirically or intuitively optimizing the design of such non-traditional ADC is challenging Highlighting some new guiding principles for designing non-traditional ADCs via a deep-dive on degrader antibody conjugate design, guided by vignettes of integrated lab-to-model workflows powered by Quantitative…Read more

day: Conference Day One